Peptides and blends explored for growth-hormone signaling, body composition, and exercise recovery.
| Item | Content / Composition |
|---|---|
| 2X Blend 1A combination of CJC-1295 and ipamorelin marketed to affect growth-hormone signaling. | CJC-1295 / Ipamorelin |
| 2X Blend 2 SMLTesamorelin plus ipamorelin: compounds that influence growth-hormone signaling. | Tesamorelin / Ipamorelin |
| 2X Blend 2 LRGA larger listed tesamorelin/ipamorelin blend; promoted for body composition. | Tesamorelin / Ipamorelin |
| 3X BlendA blend of tesamorelin, MGF and ipamorelin marketed for muscle recovery. | Tesamorelin / MGF / Ipamorelin |
| 4X BlendA combination of GHRP, tesamorelin, MGF and ipamorelin targeting growth-hormone-related pathways. | GHRP / Tesamorelin / MGF / Ipamorelin |
| IGF-1 LR3A modified form of insulin-like growth factor 1 studied for its effects on cellular growth and muscle-related signaling. | 1 mg |
| SermorelinA growth-hormone-releasing hormone analogue that stimulates pituitary growth-hormone release. | 10 mg |
| GHRP-2A growth-hormone-releasing peptide studied for stimulating growth-hormone secretion. | 10 mg |
| MOTS-CA mitochondria-derived peptide studied for possible metabolic and exercise-related signaling, primarily in preclinical research. | 10 mg |